These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16137047)

  • 1. [Effects of parathyroid hormone on osteoprotegerin expression and osteoprotegerin ligand and their related cytokines in human osteoblasts].
    Su X; Liao EY; Peng J; Liu SP; Dai RC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):562-5. PubMed ID: 16137047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells].
    Su X; Liao EY; Peng J; Wu XP
    Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):800-3. PubMed ID: 14636471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of estrogen on osteoprotegerin, osteoclast differentiation factor and macrophage colony stimulating factor mRNA expressions in ovariectomized rat bone tissue].
    Wang Q; Wang KZ; Dang XQ; Shi ZB; Pei XW; Bai CY; Jia XW
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):532-4. PubMed ID: 16624776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
    Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
    Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
    Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
    Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation.
    Yang L; Hai Y; Zhou JL
    Chin Med J (Engl); 2011 Jul; 124(13):2033-7. PubMed ID: 22088466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells.
    Zhang F; Wang CL; Koyama Y; Mitsui N; Shionome C; Sanuki R; Suzuki N; Mayahara K; Shimizu N; Maeno M
    Connect Tissue Res; 2010 Oct; 51(5):359-69. PubMed ID: 20497006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.
    Chamoux E; Houde N; L'Eriger K; Roux S
    J Cell Physiol; 2008 Aug; 216(2):536-42. PubMed ID: 18338379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts].
    Tian QX; Huang GY; Zhou JL; Liu QH; DU XR
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1501-5. PubMed ID: 17785093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts.
    Persson E; Lerner UH
    J Cell Biochem; 2011 Dec; 112(12):3732-41. PubMed ID: 21815197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL).
    Vishvanath A; Itinteang T; Tan ST; Day DJ
    Histopathology; 2011 Sep; 59(3):397-406. PubMed ID: 22034880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Kruger MC
    J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of intermittent negative pressure on mRNA expression of osteoprotegerin and osteoprotegerin ligand in human BMSCs].
    Yang Z; Zhang Y; Liu M; Guo X; Xu P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Nov; 22(11):1354-7. PubMed ID: 19068606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
    Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
    Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium butyrate stimulates mineralized nodule formation and osteoprotegerin expression by human osteoblasts.
    Katono T; Kawato T; Tanabe N; Suzuki N; Iida T; Morozumi A; Ochiai K; Maeno M
    Arch Oral Biol; 2008 Oct; 53(10):903-9. PubMed ID: 18406397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL; Zheng F; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.